PKI 14-22 amide,myristoylated
Catalogue number:
HY-P1291-1mg
Supplier:
Size:
1 mg
Product is available in:
CAS Number:
201422-03-9
Purity:
99.65
Molecular Weight:
1209.49
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
PKI 14-22 amide, myristoylated is a selective, cAMP-dependent, competitive PKA inhibitor with Ki=~36 nM. The myristoylation modification of PKI 14-22 amide, myristoylated makes it more permeable to cell membranes and blood-brain barriers than the precursor molecule. PKI 14-22 amide, myristoylated can block the phosphorylation of cAMP-dependent downstream targets (such as CREB). PKI 14-22 amide, myristoylated can prevent the development of morphine analgesic tolerance in mice, and also inhibits protein translation and negative-strand RNA synthesis of Zika virus. PKI 14-22 amide, myristoylated can be used in research fields such as opioid tolerance mechanisms and antiviral drugs[1][2][3].